SCHEMBL5648271

SCHEMBL5648271

O=C(N1CCc2ccccc21)n1ccnc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.53
STAT3 P40763 1/20 0.52
TSHR P16473 4/20 0.51
ALOX15 P16050 2/20 0.51
POLB P06746 2/20 0.51
NR4A1 P22736 1/20 0.51
ALDH1A1 P00352 5/20 0.50
LMNA P02545 2/20 0.50
HPGD P15428 1/20 0.50
GAA P10253 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MAPT P10636 2/20 0.49
KMT2A Q03164 2/20 0.49
HTR2C P28335 1/20 0.49
MAPK1 P28482 1/20 0.49
MEN1 O00255 1/20 0.49
SIGMAR1 Q99720 1/20 0.47
FAAH O00519 1/20 0.47
MGLL Q99685 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1855923 0.92 SMN1; SMN2 (0.57) NOTUMTSHRPOLBALDH1A1HPGD
SCHEMBL17117378 0.79 NOTUM (0.72) NOTUMTSHRPOLBALDH1A1LMNA
SCHEMBL29804966 0.79 NOTUM (0.72) NOTUMTSHRPOLBALDH1A1LMNA
SCHEMBL5563619 0.77 ROCK2 (0.53) FAAHMGLL
SCHEMBL18292127 0.77 NOTUM (0.56) NOTUMPOLBALDH1A1LMNAMAPT
SCHEMBL24937812 0.77 NOTUM (0.59) NOTUMSTAT3TSHRALOX15POLB
SCHEMBL24937731 0.76 NOTUM (0.58) NOTUMSTAT3TSHRALOX15POLB
Thiophene SCHEMBL27950133 0.74 NOTUM (0.53) NOTUMTSHRPOLBALDH1A1LMNA
SCHEMBL4871191 0.74 MGLL (0.49) NOTUMPOLBLMNAMAPTKMT2A
SCHEMBL7425575 0.74 MAPT (0.58) ALDH1A1LMNANPSR1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020244637-A1 TRICYCLIC COMPOUNDS AND THEIR USE HUTCHISON MEDIPHARMA LIMITED (CN) 2020-12-10 WO disclosed
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL NOTUM 17/4885STAT3 4392/4885TSHR 658/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL NOTUM 43/4885STAT3 4505/4885TSHR 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.